Tapewire

NYSE · USD

HCA

HCA Healthcare, Inc.

Export transactions ↓
Tapewire entity
2929
SEC CIK
0000860730
Parsed reports
883

Last 12 months

Inside the activity.

0 purchase rows · 13 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 2026012
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 05, 2018 Filed Feb 7, 2018 20:25 UTC
Morgan Sandra L.SVP-Provider Relations
Exercise / conversionRestricted Stock Units · Derivative 500 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-008290 · doc4.xml · derivative · entry 4

Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 500 shares

Expires 2024-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
February 05, 2018 Filed Feb 7, 2018 20:25 UTC
Morgan Sandra L.SVP-Provider Relations
Tax withholdingCommon Stock 149 $95.89 $14,287.61
Disclosure

SEC source: 0001209191-18-008290 · doc4.xml · nonDerivative · entry 2

Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,260.8654

Read SEC document
February 05, 2018 Filed Feb 7, 2018 20:25 UTC
Morgan Sandra L.SVP-Provider Relations
Exercise / conversionCommon Stock 500 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-008290 · doc4.xml · nonDerivative · entry 1

Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,409.8654

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
February 05, 2018 Filed Feb 7, 2018 20:24 UTC
Englebright Jane D.SVP and Chief Nursing Officer
Exercise / conversionRestricted Stock Units · Derivative 375 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-008289 · doc4.xml · derivative · entry 3

Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 375 shares

Expires 2024-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
February 05, 2018 Filed Feb 7, 2018 20:24 UTC
Englebright Jane D.SVP and Chief Nursing Officer
Tax withholdingCommon Stock 112 $95.89 $10,739.68
Disclosure

SEC source: 0001209191-18-008289 · doc4.xml · nonDerivative · entry 2

Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,745

Read SEC document
February 05, 2018 Filed Feb 7, 2018 20:24 UTC
Englebright Jane D.SVP and Chief Nursing Officer
Exercise / conversionCommon Stock 375 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-008289 · doc4.xml · nonDerivative · entry 1

Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,857

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
February 05, 2018 Filed Feb 7, 2018 20:24 UTC
Cuffe Michael S.President-Physician Services
Exercise / conversionRestricted Stock Units · Derivative 1,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-008288 · doc4.xml · derivative · entry 3

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,000 shares

Expires 2024-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
February 05, 2018 Filed Feb 7, 2018 20:24 UTC
Cuffe Michael S.President-Physician Services
Tax withholdingCommon Stock 284 $95.89 $27,232.76
Disclosure

SEC source: 0001209191-18-008288 · doc4.xml · nonDerivative · entry 2

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,089.4951

Read SEC document
February 05, 2018 Filed Feb 7, 2018 20:24 UTC
Cuffe Michael S.President-Physician Services
Exercise / conversionCommon Stock 1,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-008288 · doc4.xml · nonDerivative · entry 1

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,373.4951

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
February 05, 2018 Filed Feb 7, 2018 20:23 UTC
Chari Ravi S.SVP-Clinical Excellence
Exercise / conversionRestricted Stock Units · Derivative 500 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-008287 · doc4.xml · derivative · entry 3

Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 500 shares

Expires 2024-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
February 05, 2018 Filed Feb 7, 2018 20:23 UTC
Chari Ravi S.SVP-Clinical Excellence
Tax withholdingCommon Stock 149 $95.89 $14,287.61
Disclosure

SEC source: 0001209191-18-008287 · doc4.xml · nonDerivative · entry 2

Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 351

Read SEC document
February 05, 2018 Filed Feb 7, 2018 20:23 UTC
Chari Ravi S.SVP-Clinical Excellence
Exercise / conversionCommon Stock 500 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-008287 · doc4.xml · nonDerivative · entry 1

Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
February 02, 2018 Filed Feb 2, 2018 20:12 UTC
Torres Kathryn A.SVP-Payer Contracting & Align.
SaleCommon Stock 5,000 $100.93 $504,664.00
Disclosure

SEC source: 0001209191-18-007258 · doc4.xml · nonDerivative · entry 4

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,735

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.9256 to $100.9341, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 02, 2018 Filed Feb 2, 2018 19:54 UTC
Reiner Deborah MSVP - Mktg. & Communications
SaleCommon Stock 6,545 $101.54 $664,579.30
Disclosure

SEC source: 0001209191-18-007238 · doc4.xml · nonDerivative · entry 7

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
February 02, 2018 Filed Feb 2, 2018 19:33 UTC
Chari Ravi S.SVP-Clinical Excellence
SaleCommon Stock 5,702 $102.01 $581,655.32
Disclosure

SEC source: 0001209191-18-007219 · doc4.xml · nonDerivative · entry 8

Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.00 to $102.041, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 20:14 UTC
Wyatt Christopher F.SVP & Controller
GiftCommon Stock 350 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-007261 · doc4.xml · nonDerivative · entry 1

Wyatt Christopher F. · CIK 0001673365 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,157

Read SEC document
February 01, 2018 Filed Feb 2, 2018 20:10 UTC
Sowell Joseph A IIISVP; Chief Development Officer
SaleCommon Stock 16,830 $101.23 $1,703,711.00
Disclosure

SEC source: 0001209191-18-007254 · doc4.xml · nonDerivative · entry 2

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,386

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2015.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.065 to $101.5901, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 20:10 UTC
Sowell Joseph A IIISVP; Chief Development Officer
SaleCommon Stock 13,365 $100.76 $1,346,646.71
Disclosure

SEC source: 0001209191-18-007254 · doc4.xml · nonDerivative · entry 1

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,216

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2015.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.33 to $101.04, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:55 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 5,518 $0.00 Strike: $15.91 $0.00
Disclosure

SEC source: 0001209191-18-007239 · doc4.xml · derivative · entry 20

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,518 shares

Expires 2019-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F11 · derivative.exercise_date: The option vested at the end of fiscal year 2009 based upon the achievement of certain annual EBITDA performance targets.

F6 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:55 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 9,829 $0.00 Strike: $11.36 $0.00
Disclosure

SEC source: 0001209191-18-007239 · doc4.xml · derivative · entry 19

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,829 shares

Expires 2019-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F10 · derivative.exercise_date: The option vested at the end of fiscal year 2012 based upon the achievement of certain annual EBITDA performance targets.

F6 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:55 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 5,518 $0.00 Strike: $10.92 $0.00
Disclosure

SEC source: 0001209191-18-007239 · doc4.xml · derivative · entry 18

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,518 shares

Expires 2019-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F6 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:55 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 9,829 $0.00 Strike: $7.47 $0.00
Disclosure

SEC source: 0001209191-18-007239 · doc4.xml · derivative · entry 17

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,829 shares

Expires 2019-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F6 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:55 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 11,036 $0.00 Strike: $6.48 $0.00
Disclosure

SEC source: 0001209191-18-007239 · doc4.xml · derivative · entry 16

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,036 shares

Expires 2019-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F9 · derivative.exercise_date: The option vested at the end of fiscal years 2010 and 2011 based upon the achievement of certain annual EBITDA performance targets.

F6 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:55 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 5,518 $0.00 Strike: $6.48 $0.00
Disclosure

SEC source: 0001209191-18-007239 · doc4.xml · derivative · entry 15

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,518 shares

Expires 2019-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F6 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:55 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 11,038 $0.00 Strike: $5.98 $0.00
Disclosure

SEC source: 0001209191-18-007239 · doc4.xml · derivative · entry 14

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,038 shares

Expires 2019-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F8 · derivative.exercise_date: The option vested in equal increments (i) at the end of fiscal year 2012 upon the achievement of certain annual EBITDA performance targets and (ii) upon a change in control (as defined in the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates as Amended and Restated) of the Issuer which occurred effective November 1, 2013.

F6 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:55 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 16,556 $0.00 Strike: $5.98 $0.00
Disclosure

SEC source: 0001209191-18-007239 · doc4.xml · derivative · entry 13

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,556 shares

Expires 2019-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F7 · derivative.exercise_date: The option was scheduled to vest in three equal annual installments beginning on August 27, 2012. A change in control of the Issuer occurred effective November 1, 2013, resulting in the accelerated vesting of the option as to the shares that remained unvested.

F6 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:55 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 9,832 $0.00 Strike: $5.34 $0.00
Disclosure

SEC source: 0001209191-18-007239 · doc4.xml · derivative · entry 12

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,832 shares

Expires 2019-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F5 · derivative.exercise_date: On February 25, 2009, the reporting person was granted an option to purchase 29,494 shares of common stock, which vest upon achievement of certain predetermined investment return targets. 1/3 of the option vested as a result of the achievement of certain specified investment return targets as of the closing of the initial public offering of the Issuer's securities on March 15, 2011, 1/3 of the option vested as a result of the achievement of certain specified investment return targets as of December 31, 2011 and 1/3 of the option vested as a result of the achievement of certain specified investment return targets as of December 31, 2012.

F6 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:55 UTC SaleCommon Stock 23,762 $102.87 $2,444,458.72
Disclosure

SEC source: 0001209191-18-007239 · doc4.xml · nonDerivative · entry 10

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,673

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.57 to $103.19, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:55 UTC SaleCommon Stock 24,700 $101.98 $2,518,982.57
Disclosure

SEC source: 0001209191-18-007239 · doc4.xml · nonDerivative · entry 9

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,435

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.58 to $102.55, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:55 UTC Tax withholdingCommon Stock 14,976 $102.24 $1,531,146.24
Disclosure

SEC source: 0001209191-18-007239 · doc4.xml · nonDerivative · entry 8

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,135

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:55 UTC Exercise / conversionCommon Stock 5,518 $15.91 $87,798.00
Disclosure

SEC source: 0001209191-18-007239 · doc4.xml · nonDerivative · entry 7

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,111

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:55 UTC Exercise / conversionCommon Stock 9,829 $11.36 $111,642.70
Disclosure

SEC source: 0001209191-18-007239 · doc4.xml · nonDerivative · entry 6

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,593

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:55 UTC Exercise / conversionCommon Stock 5,518 $10.92 $60,238.90
Disclosure

SEC source: 0001209191-18-007239 · doc4.xml · nonDerivative · entry 5

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,764

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:55 UTC Exercise / conversionCommon Stock 9,829 $7.47 $73,460.96
Disclosure

SEC source: 0001209191-18-007239 · doc4.xml · nonDerivative · entry 4

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:55 UTC Exercise / conversionCommon Stock 16,554 $6.48 $107,223.57
Disclosure

SEC source: 0001209191-18-007239 · doc4.xml · nonDerivative · entry 3

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,417

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:55 UTC Exercise / conversionCommon Stock 27,594 $5.98 $165,070.07
Disclosure

SEC source: 0001209191-18-007239 · doc4.xml · nonDerivative · entry 2

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,863

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:55 UTC Exercise / conversionCommon Stock 9,832 $5.34 $52,488.13
Disclosure

SEC source: 0001209191-18-007239 · doc4.xml · nonDerivative · entry 1

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,269

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:52 UTC Exercise / conversionStock Appreciation Right · Derivative 17,500 $0.00 Strike: $22.95 $0.00
Disclosure

SEC source: 0001209191-18-007236 · doc4.xml · derivative · entry 9

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,500 shares

Expires 2022-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:52 UTC Exercise / conversionStock Appreciation Right · Derivative 17,500 $0.00 Strike: $22.95 $0.00
Disclosure

SEC source: 0001209191-18-007236 · doc4.xml · derivative · entry 8

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,500 shares

Expires 2022-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:52 UTC Exercise / conversionStock Appreciation Right · Derivative 37,500 $0.00 Strike: $22.87 $0.00
Disclosure

SEC source: 0001209191-18-007236 · doc4.xml · derivative · entry 7

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 37,500 shares

Expires 2022-08-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:52 UTC Exercise / conversionStock Appreciation Right · Derivative 37,500 $0.00 Strike: $22.87 $0.00
Disclosure

SEC source: 0001209191-18-007236 · doc4.xml · derivative · entry 6

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 37,500 shares

Expires 2022-08-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on August 7, 2013.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:52 UTC Exercise / conversionCommon Stock 56,813 $102.24 $5,808,561.12
Disclosure

SEC source: 0001209191-18-007236 · doc4.xml · nonDerivative · entry 3

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,082

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:52 UTC Exercise / conversionCommon Stock 35,000 $22.95 $803,250.00
Disclosure

SEC source: 0001209191-18-007236 · doc4.xml · nonDerivative · entry 2

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,895

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:52 UTC Exercise / conversionCommon Stock 75,000 $22.87 $1,715,250.00
Disclosure

SEC source: 0001209191-18-007236 · doc4.xml · nonDerivative · entry 1

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,895

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:47 UTC
JOHNSON R MILTONDirector · Chairman & CEO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 640,070 $0.00 Strike: $22.64 $0.00
Disclosure

SEC source: 0001209191-18-007231 · doc4.xml · derivative · entry 10

JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 640,070 shares

Expires 2019-10-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F4 · derivative.exercise_date: Two thirds of the option was vested upon grant on October 6, 2009, and one third of the option vested on November 17, 2009

F3 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:47 UTC
JOHNSON R MILTONDirector · Chairman & CEO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 213,356 $0.00 Strike: $17.65 $0.00
Disclosure

SEC source: 0001209191-18-007231 · doc4.xml · derivative · entry 9

JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 213,356 shares

Expires 2019-10-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F3 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:47 UTC
JOHNSON R MILTONDirector · Chairman & CEO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 213,365 $0.00 Strike: $13.21 $0.00
Disclosure

SEC source: 0001209191-18-007231 · doc4.xml · derivative · entry 8

JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 213,365 shares

Expires 2019-10-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F3 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:47 UTC
JOHNSON R MILTONDirector · Chairman & CEO
Tax withholdingCommon Stock 543,348 $102.24 $55,551,899.52
Disclosure

SEC source: 0001209191-18-007231 · doc4.xml · nonDerivative · entry 5

JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 950,378

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:47 UTC
JOHNSON R MILTONDirector · Chairman & CEO
Exercise / conversionCommon Stock 640,070 $22.64 $14,492,144.91
Disclosure

SEC source: 0001209191-18-007231 · doc4.xml · nonDerivative · entry 4

JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,493,726

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 01, 2018 Filed Feb 2, 2018 19:47 UTC
JOHNSON R MILTONDirector · Chairman & CEO
Exercise / conversionCommon Stock 213,356 $17.65 $3,765,114.67
Disclosure

SEC source: 0001209191-18-007231 · doc4.xml · nonDerivative · entry 3

JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 853,656

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.